Hemofil-M 250IU Injection: Coagulation Factor for Medical Use

Uses:

• Treatment of Hemophilia A.

Therapeutic Effects:

• Facilitates the clotting process.
• Helps prevent and control bleeding episodes in individuals with hemophilia A and other conditions associated with low factor VIII levels.
• Reduces the chance of complications such as bleeding, excessive blood loss, and related health issues.

Interaction with Other Drugs:

• Inform your physician about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment.
• Certain medications may interact with Hemofil-M 250IU Injection and cause undesirable side effects.

Storage:

• Store Hemofil-M 250IU Injection in the refrigerator at (2°C to 8°C).
• Do not freeze.

Administration:

• Hemofil-M 250IU Injection is usually administered through a vein (intravenously) by your physician in a hospital setting.
• Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.
• Do not self-administer this injection.

Safety Advices:

• Pregnancy: ask your doctor for more advice before starting the treatment with Hemofil-M 250IU Injection.
• Breastfeeding: consult your doctor before starting the treatment with Hemofil-M 250IU Injection.
• Lungs: notify your doctor if you have lung disease before starting the treatment.
• Liver: inform your doctor if you have liver disease before starting the treatment.
• Alcohol: it is unknown whether consuming alcohol while taking Hemofil-M 250IU Injection is safe. Please speak with your physician.
• Driving: Hemofil-M 250IU Injection does not affect your ability to drive and operate heavy machinery. Inform your physician if you face any symptoms that alter your concentration.

Side Effects:

• Serious: allergic reaction (anaphylactic shock) or a hypersensitivity reaction.
• Common: reddening of the skin, burning and stinging at the injection site, chills, flushing, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing.

Word of Advice:

• If you regularly or repeatedly receive human plasma-derived Hemofil-M 250IU Injection products, your doctor may recommend vaccination against hepatitis A and B.
• Good dental hygiene is important to maintain oral health and prevent tooth and gum disease.
• If you notice any changes in your symptoms or have concerns about the treatment with Hemofil-M 250IU Injection, immediately communicate them to your physician for more advice.

FAQs:

1. Is Hemofil-M 250IU Injection derived from human plasma or produced through recombinant DNA technology?
   • Hemofil-M 250IU Injection can be derived from human plasma, which undergoes a purification process or is produced using recombinant DNA technology.
2. Can Hemofil-M 250IU Injection be used in children?
   • Yes, Hemofil-M 250IU Injection can be used in children. The dosage and administration may vary based on the child's age, weight, and needs.
3. Are there any potential side effects of Hemofil-M 250IU Injection?
   • The most common side effect of Hemofil-M 250IU Injection is the development of inhibitors (antibodies) that can interfere with the effectiveness of the treatment. Other possible side effects include allergic reactions, infusion site reactions, and the risk of blood clots.
4. How is Hemofil-M 250IU Injection administered?
   • Hemofil-M 250IU Injection is administered intravenously (IV) through a needle inserted into a vein by your physician in a hospital setting. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.
5. Can Hemofil-M 250IU Injection be used during surgery or dental procedures?
   • Hemofil-M 250IU Injection can be used before surgery or dental procedures in individuals with hemophilia A to prevent excessive bleeding. Coordinating with the healthcare team is important to ensure proper dosing and timing.

Fact Box:

• Molecule Name: Factor VIII
• Therapeutic class: Antihemophilic agents
• Pharmacological class: Miscellaneous coagulation modifiers
• Indications: Treatment of Hemophilia A

Tags: Hemofil-M, Injection, 250IU, MedicalGoods, Medication, Healthcare, Pharma, Medicine, BloodClottingFactor, HemophiliaTreatment